Rare diseases
Investigational molecules
Locations
Back to Germany212 clinical trials in Homburg, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effectiveness and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
GermanyStudy on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer's Disease
GermanyStudy on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy
GermanyStudy on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma
GermanyStudy on the Effectiveness and Safety of OCS-01 Eye Drops with Dexamethasone for Patients with Diabetic Macular Edema
GermanyStudy on Acalabrutinib with Drug Combination for Patients 75 and Older with Untreated Diffuse Large B-Cell Lymphoma
GermanyStudy of Acalabrutinib for Patients with Chronic Lymphocytic Leukemia
GermanyStudy on the Safety and Effectiveness of Ripasudil Eye Drops for Patients with Fuchs Endothelial Corneal Dystrophy After Descemetorhexis
GermanyStudy on Bendamustine, Obinutuzumab, Zanubrutinib, and Venetoclax for Patients with Relapsed Chronic Lymphocytic Leukemia
GermanyStudy on Giredestrant and Everolimus for Patients with Estrogen Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer
GermanyStudy of Durvalumab with Radiation Therapy for Patients with Early Stage Non-Small Cell Lung Cancer and Osimertinib for Those with EGFR Mutation
GermanyStudy on the Effectiveness and Safety of Ralinepag for Patients with Pulmonary Arterial Hypertension
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on lymphoma and leukemia treatments, including studies evaluating novel therapies for chronic lymphocytic leukemia and various types of B-cell lymphomas.
Multiple trials exploring CAR-T cell therapies and targeted treatment combinations.
Comprehensive studies investigating treatments for various types of breast cancer, particularly focusing on hormone receptor-positive and HER2-positive disease.
Evaluating new combination therapies and targeted treatments for improved patient outcomes.
Studies addressing heart failure prevention and treatment, with innovative approaches to reducing cardiovascular risks.
Testing novel drug combinations to improve cardiovascular outcomes and patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
